Literature DB >> 17879370

Hormone replacement therapy and lung cancer risk in Chinese.

Kuan-Yu Chen1, Chin-Fu Hsiao, Gee-Chen Chang, Yin-Huang Tsai, Wu-Chou Su, Reury-Perng Perng, Ming-Shyan Huang, Chao A Hsiung, Chien-Jen Chen, Pan-Chyr Yang.   

Abstract

BACKGROUND: The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics compared with Western patient populations. The authors investigated whether HRT may reduce lung cancer risk in Taiwan.
METHODS: The authors used a case-control study design to investigate 826 women with lung cancer and 531 healthy controls. Personal interviews based on a structured questionnaire were performed to collect information on HRT use of at least 3 months, age, ethnicity, active and passive smoking, exposure to air pollution, cooking or incense fumes, body mass index (BMI), menopause, and family history of cancers.
RESULTS: HRT use was associated with reduced lung cancer risk with a multivariate, adjusted odds ratio of 0.70 (95% CI, 0.53-0.94; P = .019). HRT use was associated with reduced odds ratio of lung cancer in all subset analyses stratified by histology, active and passive cigarette smoking, BMI, history of incense burning, cooking, and motorcycle riding, as well as family history of certain cancers.
CONCLUSIONS: This study confirmed that HRT is associated with a reduced lung cancer risk. The results appeared to be applicable to Chinese female population groups.

Entities:  

Mesh:

Year:  2007        PMID: 17879370     DOI: 10.1002/cncr.22987

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Reproductive and hormonal factors and the risk of nonsmall cell lung cancer.

Authors:  Cari L Meinhold; Amy Berrington de González; Elise D Bowman; Alina V Brenner; Raymond T Jones; James V Lacey; Christopher A Loffredo; Donna Perlmutter; Sara J Schonfeld; Glenwood E Trivers; Curtis C Harris
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

2.  Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Lauren Schwartz; Margaret R Spitz; Yikyung Park; Albert R Hollenbeck; Gretchen L Gierach
Journal:  Cancer Causes Control       Date:  2012-02-25       Impact factor: 2.506

3.  Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies.

Authors:  Ann G Schwartz; Roberta M Ray; Michele L Cote; Judith Abrams; Robert J Sokol; Susan L Hendrix; Chu Chen; Rowan T Chlebowski; F Allan Hubbell; Charles Kooperberg; JoAnn E Manson; Mary Jo O'Sullivan; Thomas Rohan; Marcia L Stefanick; Jean Wactawski-Wende; Heather Wakelee; Michael S Simon
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

4.  Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study.

Authors:  Christina S Baik; Gary M Strauss; Frank E Speizer; Diane Feskanich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-25       Impact factor: 4.254

5.  Lung cancer in women: role of estrogens.

Authors:  Subhankar Chakraborty; Apar Kishor Ganti; Alissa Marr; Surinder K Batra
Journal:  Expert Rev Respir Med       Date:  2010-08       Impact factor: 3.772

6.  Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort.

Authors:  Louise A Brinton; Gretchen L Gierach; Abegail Andaya; Yikyung Park; Arthur Schatzkin; Albert R Hollenbeck; Margaret R Spitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

7.  Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study.

Authors:  Christopher G Slatore; Jason W Chien; David H Au; Jessie A Satia; Emily White
Journal:  J Clin Oncol       Date:  2010-02-16       Impact factor: 44.544

8.  Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.

Authors:  Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

9.  Incense use and respiratory tract carcinomas: a prospective cohort study.

Authors:  Jeppe T Friborg; Jian-Min Yuan; Renwei Wang; Woon-Puay Koh; Hin-Peng Lee; Mimi C Yu
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

10.  Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study.

Authors:  Adeline Seow; Woon-Puay Koh; Renwei Wang; Hin-Peng Lee; Mimi C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.